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Abstract 
Background: The aim of this study was to evaluate 24 protocols for the production of platelet rich fibrin (PRF) 
produced via horizontal centrifugation to better understand cell separation following protocols at various times and 
speeds.
Methods: All protocols were compared utilizing a recent method to quantify cells in PRF in 1 mL sequential layers 
pipetted from the upper layer downwards until all 10 mL were harvested. In total, 960 complete blood counts (CBCs) 
were investigated. Both solid and liquid‑based PRF protocols were investigated following 24 protocols involving 6 rel‑
ative centrifugal force (RCF) values (100, 200, 400, 700, 1000 and 1200g) at 4 centrifugation times (3, 5, 8 and 12 min).
Results: In general, platelets could more easily accumulate in the upper 4 layers when compared to leukocytes 
owing to their lower cellular density. Protocol time seemed to have a greater impact on the final cell layer separation 
when compared to the effect of speed. Protocols of greater than 8 min at 400g led to no leukocyte accumulation in 
the upper PRF layers (found specifically within the buffy coat). Protocols at or below 200g were unable to effectively 
accumulate platelets/leukocytes. The optimal centrifugation speed and time for solid‑PRF ranged between 400 and 
700g for 8 min. It was noted that variability in patient baseline platelet/leukocyte/erythrocyte counts (hematocrit) 
significantly affected cell layer separation. This finding was more pronounced at lower centrifugation speeds.
Conclusions: Within the investigated ranges, a protocol of 700g for 8 min presented the highest yield of platelets/
leukocytes evenly distributed throughout the upper PRF layers.
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Background
Platelet concentrates, including platelet-rich plasma 
(PRP) and platelet-rich fibrin (PRF), have been widely 
utilized in many fields of medicine as a scaffold capa-
ble of facilitating tissue regeneration [1]. PRP was first 
introduced over 20  years ago as a specific regenerative 
modality aimed at concentrating platelets from whole 
blood [2–6]. PRP contains an array of naturally derived 
autologous growth factors, including platelet-derived 
growth factor (PDGF), transforming growth factor beta 
(TGF-β), and vascular endothelial growth factor (VEGF). 
This set of growth factors is responsible for facilitat-
ing new blood vessel formation (angiogenesis) as well 
as inducing the cell migration and proliferation of vari-
ous cell types [2–6]. While PRP has been widely utilized 
in many fields of medicine for over 2 decades, one of the 
major reported limitations includes its use of anticoagu-
lants, known suppressors of clotting and thereby wound 
healing [2, 7, 8]. Nevertheless, the simplicity and low cost 
of harvesting peripheral blood and concentrating blood-
derived growth factors and cells using a centrifuge has 
long been considered an effective and easy-to-obtain 
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source of natural growth factors for tissue regeneration 
[9, 10].
PRF was thereafter developed as a second-genera-
tion platelet concentrate with the aim of anticoagu-
lant removal [11]. This concentrate has frequently been 
termed leukocyte and platelet-rich fibrin (L-PRF) owing 
to the desired incorporation of leukocytes most com-
monly using a ~ 700g for 12-min protocol [12]. Since 
anticoagulants are removed, blood is subject to clotting 
over time within the blood collection tube, and it there-
fore becomes critical that the treating clinician begin 
centrifugation shortly following blood collection to sep-
arate blood layers [13]. One key advantage is the fibrin 
matrix formed in PRF, which favors the slow and gradual 
release of growth factors over time when compared to 
that in PRP [14]. Furthermore, by reducing centrifugation 
speeds and time, a liquid-PRF (injectable-PRF or i-PRF) 
was developed with an increased concentration of plate-
lets and leukocytes [15].
Very recently, it was reported that the horizontal cen-
trifugation of PRF was superior at accumulating platelets 
and leukocytes when compared to the results from stand-
ard fixed-angle centrifuges utilized to produce solid-PRF 
[16]. Both solid-based and liquid-based PRF matrices 
were obtained with up to 3.5-fold improvements in plate-
let/leukocyte numbers and/or concentrations [16]. While 
the use of horizontal centrifugation for the production 
of PRF remains relatively new, to date, no studies have 
investigated the effect of various centrifugation proto-
cols on the final outcomes of PRF. Therefore, the aim of 
the present study was to optimize both solid- and liquid-
based PRF matrices on a horizontal centrifuge by inves-
tigating a series of 24 protocols. The following 6 RCF 
values (100g, 200g, 400g, 700g, 1000g and 1200g) were 
investigated and compared at 4 different centrifugation 
times (3, 5, 8 and 12 min) to determine cell numbers and 
cellular concentrations.
Methods
Preparation of PRF
Blood samples were collected with informed con-
sent from 4 volunteer donors. All procedures involv-
ing human participants in this study were performed in 
accordance with the ethical standards of the institutional 
and/or national research committee and with the 1964 
Declaration of Helsinki and its later amendments. All 
blood samples were collected in Wuhan, China and uti-
lized in accordance to the guidelines by The University of 
Wuhan ethical standards and guidelines via an IRB pro-
cess (Internal Review Board, University of Wuhan). An 
ethical request was waived by the IRB for this study since 
blood was not used as identifiable sources [15]. Blood 
samples were collected with the written informed con-
sent of 4 volunteer donors.
The factors that affect fibrin clot formation and struc-
ture include genetic factors, acquired factors (such as 
abnormal concentration of thrombin and factor XIII in 
plasma, blood flow, platelet activation, oxidative stress, 
hyperglycemia, hyperhomocysteinemia, medications, 
and cigarette smoking), and other parameters (such as 
microgravity, pH, temperature, reducing agents, and con-
centration of chloride and calcium ions) [17]. All donors 
were confirmed to be without any of the above condi-
tions. The CBC of the donors were also investigated prior 
to beginning the experiments to confirm standard cell 
count ranges.
The production of PRF was obtained utilizing an 
Eppendorf 5702 horizontal centrifuge (Hamburg, Ger-
many). Each of the 4 volunteers donated 24 vials of blood 
in standard 10 mL plastic collection tubes (240 mL total; 
Chixin Biotech, Wuhan, China). The following 24 proto-
cols were investigated, which included 6 different RCF 
values of 100g, 200g, 400g, 700g, 1000g and 1200g and 4 
centrifugation times of 3, 5, 8 and 12 min, according to 
Fig. 1.
Quantification of cells found in PRF
To accurately quantify the cells found in PRF, a sequential 
pipetting protocol was utilized as previously described 
[16]. The protocol involves sequentially pipetting 1  mL 
layers from the top layer down to the bottom 1 mL layer, 
as depicted in Fig.  2. Notably, during the harvesting of 
the 1  mL layers, one sample was collected between the 
plasma/buffy coat and the red blood cell (RBC) layer. 
This layer was marked within each figure to represent the 
location of the buffy coat and displayed graphically with 
arrows (see Figs. 3, 4, 5 and 6 in Results as an example) 
to represent the separation between the yellow plasma 
and RBC layers. Furthermore, the total volumes (in mL) 
of plasma were recorded from each protocol to calculate 
the total cell numbers and concentrations following each 
protocol. Each blood sample (1 mL) was then then placed 
into 1.5 mL plastic tubes with anti-coagulants (2 mg/mL 
EDTA-K2) to allow for the blood samples to thereafter be 
sent for complete blood count (CBC) analysis, in which 
the total number of leukocytes, RBCs platelets, neutro-
phils, lymphocytes and monocytes were calculated from 
each sample using a Sysmex XN-550 (Sysmex Corpora-
tion, Kobe, Japan) based on fluorescence flow cytom-
etry. In total, 960 samples were sent for CBC analysis 
and investigated accordingly thereafter. Each sample was 
displayed graphically using GraphPad Prism 6.0 software 
(GraphPad Software, Inc., La Jolla, CA, USA). Data aver-
ages with standard errors were presented in terms of per-
centages of total yield of platelets and leukocytes as well 
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as final concentration from baseline values. Furthermore, 
informative trends were also reported from the data 
presented.
Results
Cell numbers following centrifugation using various 
protocols
Following centrifugation utilizing the various protocols, 
1  mL sequential layers were sent for CBC analysis, and 
each protocol incorporated 10 CBCs from each donor 
sample when compared to baseline levels. Several trends 
were observed within the present study owing to the 
extensive number of CBC evaluations (960 total evalua-
tions) performed throughout the study.
Figure  3 demonstrates the overall final volume of 
plasma of each of the protocols, along with the total 
yield and concentrations of platelets and leukocytes 
above baseline values. Note that of each of the protocols, 
a 200g for 5  min protocol led to the highest concentra-
tion of platelets/leukocytes. The best yield of leukocytes 
was achieved after centrifugation for 8  min utilizing 
the 700, 1000 and 1200g protocols. Of those the highest 
concentration was achieved at 700g for 8 min (owing to 
the reduced total plasma volume). Another notewor-
thy trend that was apparent was that as centrifugation 
time was increased, a general increase in percent yield 
was observed, however generally speaking, an overall 
decrease in concentration was observed (Fig. 3). Further-
more, it was apparent that certain centrifugation proto-
cols that were too reduced in RCF (such as 100g) typically 
did not lead to adequate yield of cells. Furthermore, pro-
tocols that were too elevated led to a reduction in yield 
and/or concentrations.
For instance, a significantly elevated protocol (1000g or 
more for 5  min) or a lengthier 12-min protocol at 400g 
or more was either too high or lengthy to adequately dis-
tribute platelets/leukocytes within the upper plasma lay-
ers. For the production of even distribution throughout 
the upper plasma layers of PRF, the protocol best distrib-
uting platelets and leukocytes within the upper 3–5 mL 
plasma layer was observed at 700g for 8  min (Fig.  4). 
Note that platelets were evenly distributed in the upper 
PRF layer, whereas leukocytes, though primarily accu-
mulated within the upper layers, were shifted slightly 
Fig. 1 Clinical image demonstrating the plasma layer separation for the 24 protocols investigated in this study. Note that while some protocols 
reveal roughly identical plasma layer separation, the underlying cellular content in the various protocols may be drastically different
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more toward the buffy coat owing to their slightly higher 
cellular density (Fig.  4). Their overall yield was reduced 
in comparison to platelets (Fig.  3). Interestingly, when 
patients displayed slightly lower total RBCs (less hema-
tocrit – typically in women and elderly populations), cell 
separation occurred slightly faster. This effect results in 
WBCs typically found more closely related to the buffy 
coat layer (Fig.  5). Similarly, when the protocols were 
extended past 8  min (12  min), the cells continued to 
accumulate within the buffy coat layer as opposed to 
being evenly distributed throughout the PRF clot (Fig. 6).
In contrast, PRF utilized in a clinical setting as a liq-
uid formulation (injectable) does not necessarily aim 
to accumulate the highest possible yield of total plate-
lets/leukocytes in the upper plasma layer but instead 
accumulates the highest concentration of platelets and 
leukocytes for small volume injections/mixing with 
biomaterials. As such, a shorter and slower centrifu-
gation protocol is utilized to concentrate the cells in a 
smaller plasma layer (by volume). In the present study, 
protocols at 100g were inadequately effective at separat-
ing cell layers, and even a 200g protocol for 3 min did 
not result in sufficient concentrations of platelets/leu-
kocytes. The protocol which demonstrated the highest 
concentration of platelets and leukocytes was observed 
at 200g for 5  min (Fig.  3; cell distribution depicted in 
Fig.  7). Note that while the total yield of platelets and 
leukocytes was lower in the 200g for 5  min protocol 
when compared to 700g for 8 min, the overall concen-
tration was higher (Table 1).
One interesting observation in the present study was 
the variability observed among various donors when 
centrifugation was performed with identical protocols 
in different aged/gender populations (Additional file 1: 
Figs.  S1–S3). Note the difference in cell layer separa-
tion among 3 donor samples centrifuged at 700g for 
5  min. While in donor 1, the plasma layer separation 
occurred in layer 3 with ~ 3  mL of plasma (Additional 
file 1: Fig. S1), donor 3 demonstrated plasma layer sepa-
ration in layer 5 with ~ 5  mL of plasma with the exact 
same protocol (Additional file  1: Fig.  S3). This finding 
demonstrates a more than 50% increase in the total 
amount of plasma when following identical protocols 
owing to variability among donors. This result was 
due to differences in the initial baseline values of the 
platelets, leukocytes and RBCs (hematocrit levels) and 
may represent additional variability among a standard 
population.
Fig. 2 Illustration demonstrating the proposed novel method to quantify cell types following the centrifugation of PRF. One of the limitations of 
the current methods utilized to investigate PRF cellular content from the whole plasma layer is the inability to accurately determine where cells 
migrate following centrifugation. By utilizing the proposed technique using the sequentially pipetting 1 mL layers from the top layer downwards, 
it is possible to quantify cell numbers in 10 samples from CBC analysis and accurately determine the precise location of each cell layer following 
centrifugation at various protocols. Note that one layer (in this case, layer 5) will contain both yellow plasma and red blood cells. This effect is 
figuratively depicted with arrows to demonstrate the location of the buffy coat where a higher concentration of platelets/leukocytes is typically 
found. Reprinted with permission [16]
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Discussion
PRF has gained tremendous momentum in recent years 
as a natural concentration of autologous growth factors 
capable of stimulating tissue regeneration. Despite its 
widespread use, to date, very little scientific data exist 
from studies investigating centrifugation protocols. 
In 2014, lower centrifugation speeds were proposed 
as a means to better accumulate growth factors and 
cells within the upper platelet-rich layers by modify-
ing L-PRF protocols from 700g down to 200g [18]. An 
approximately 20% increase in platelet concentration 
could be observed following these lower speed centrif-
ugation protocols [16]. While these previous methods 
based on histological observations allow for a relative 
estimate of the cells found in the various blood cell lay-
ers, the new methodology recently proposed by our 
group [16] allows for the precise quantification and 
concentration of cells in 1  mL incremental layers fol-
lowing centrifugation. This protocol provides research-
ers with a better ability to understand the events 
occurring following centrifugation at various protocols.
Fig. 3 Evaluation of 24 protocols utilized for the production of PRF. Data includes final volume (mL), total leukocyte and platelet yields (% of the 
total from 10 mL) as well as concentration of leukocytes and platelets above baseline values (% increase)
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The aim of the present study was therefore to utilize 
the previously established method to investigate 24 pro-
tocols on a horizontal centrifuge. Table  2 demonstrates 
the properties of blood cells, including their density, 
frequency, surface areas and surface volumes. Note that 
while platelets are the least dense of the group, minor 
Fig. 4 The concentration of cell types in each layer from 1 mL down to the 10th 1‑mL sample utilizing the solid‑PRF horizontal centrifugation 
protocol (700g for 8 min). Notice that most of the platelets are evenly distributed throughout the upper plasma layer. Similarly, white blood cells are 
primarily distributed throughout the upper 4 layers, though not as even as platelets owing to their slightly higher cellular density (Arrows represent 
the separation between the plasma and red blood cell layer (buffy coat)). Reprinted with permission [16]
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differences occur between leukocytes and RBCs, which 
greatly impacts the ability to separate blood cell layers 
based on density. Furthermore, while white blood cells 
(WBCs) are less dense when compared to RBCs (1055–
1085  kg/m3 vs. 1095–1100  kg/m3), note that WBCs are 
generally larger in size when compared to RBCs (surface 
Fig. 5 Observed variability of the concentration of cell types in each layer from 1 mL down to the 10th 1‑mL sample utilizing the same solid‑PRF 
horizontal centrifugation protocol (700g for 8 min) as depicted in Fig. 4 (owing to difference in patient gender and age). Notice that when 
compared to Fig. 4, more leukocytes are found within the buffy coat layer. This finding is a result of a patient demonstrating lower hematocrit 
counts (typically occurring in older female patients), thereby resulting in easier cell‑layer separation and more pronounced accumulation within the 
buffy coat layer (arrows represent the separation between the plasma and red blood cell layer (buffy coat))
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area 330 vs 140 µm2, radium 5–7.5 vs. 4 µm and volume 
of 200 vs. 92 µm3). In addition, RBCs greatly outnumber 
WBCs by over 1000-fold (5 million RBCs vs 5000 WBCs 
per µL). These findings greatly influence the ability to 
separate cell types in a centrifuge based on density.
A horizontal centrifuge was utilized in this study owing 
to its better ability to separate blood cell layers (up to a 
Fig. 6 The concentration of cell types in each layer from 1 mL down to the 10th 1‑mL sample utilizing a solid‑PRF horizontal centrifugation 
protocol at 700g for 12 min. Notice that when compared to Fig. 4, the higher centrifuge time resulted in more leukocytes concentrated within the 
buffy coat layer. This finding demonstrates that over time, cells migrate more toward the buffy coat layer with extended periods of time or extended 
RCF values (Arrows represent the separation between the plasma and red blood cell layer (buffy coat))
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Fig. 7 The concentration of cell types found in each layer from 1 mL down to the 10th 1‑mL sample utilizing the liquid‑PRF protocol of 200g for 
5 min. Notice that while not as many cells are located in the plasma layer, a higher concentration of platelets and leukocytes can be found owing 
to the reduced plasma volume when compared to that in the solid‑PRF protocols demonstrated in Fig. 3 (Arrows represent the separation between 
the plasma and red blood cell layer (buffy coat))
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4 times greater yield in platelets/leukocytes) and avoid 
the grouping of cells along the back distal walls of cen-
trifugation tubes as observed on fixed angle-centrifuges 
(Fig. 8) [16]. Two advantages were previously noted uti-
lizing horizontal centrifugation [16]. First, a completely 
horizontal position produced from a swing-out bucket 
allows for the greatest differential between the minimum 
and maximum radius found within a centrifugation tube 
(Fig. 8). This effect allows for a greater ability to separate 
cell layers based on disparities between the RCF-min and 
RCF-max produced within a tube. Second, a fixed-angle 
centrifuge results in more trauma to cells along the back 
walls of centrifugation tubes [16]. A recent study demon-
strated that fixed-angle centrifugation led to uneven con-
centrations of cells and growth factors, with the majority 
of cells found on the back distal side of PRF tubes with 
uneven concentrations found throughout PRF clots 
[19]. That paper highlights yet another effective method 
whereby cell layer separation can be evaluated histo-
logically via sectioning of clotted PRF membranes layer 
by layer [19]. Once allocated along the back distal tube 
surfaces, difficulty exists in effectively separating blood 
cells leading to lower yields of cells [16]. For these rea-
sons, horizontal centrifugation was recently proposed 
as a means to better separate blood cell layers for the 
production of PRF when compared to the results from 
fixed-angle centrifuges commonly utilized to produce 
solid-PRF protocols [16].
Table 1 Evaluation of 24 protocols utilized for the production of PRF
Data includes final volume (mL), total leukocyte and platelet yields (% of the total from 10 mL) as well as concentration of leukocytes and platelets above baseline 
values (% increase) (data represents average ± standard error)
100g 200g 400g 700g 1000g 1200g
Final volume (mL)
3 min 0.5 ± 0.29 1.25 ± 0.48 2.13 ± 0.31 2.25 ± 0.25 3.00 ± 0.41 3.75 ± 0.25
5 min 1 ± 0.58 1.75 ± 0.25 2.75 ± 0.25 3.75 ± 0.48 4.75 ± 0.25 5.00 ± 0.41
8 min 1.5 ± 0.65 3.25 ± 0.48 4.25 ± 0.48 5.00 ± 0.41 5.75 ± 0.25 5.75 ± 0.25
12 min 2.5 ± 0.96 4.25 ± 0.48 5.00 ± 0.41 5.75 ± 0.25 5.75 ± 0.25 5.75 ± 0.25
Total leukocytes (% total of 10 mL)
3 min 10.5 ± 0.71 18.42 ± 5.01 24.17 ± 3.08 24.33 ± 4.30 29.17 ± 5.11 35.67 ± 4.38
5 min 14.17 ± 1.18 23.75 ± 2.67 31.92 ± 3.10 40.83 ± 8.75 53.58 ± 3.48 56.58 ± 3.33
8 min 20 ± 7.07 40.79 ± 2.46 54.42 ± 5.63 62.83 ± 6.11 62.92 ± 2.75 62.17 ± 6.13
12 min 36.75 ± 4.76 45.75 ± 2.47 55.75 ± 4.25 62.50 ± 4.98 62.25 ± 3.45 54.25 ± 4.57
Concentration of leukocytes (% baseline)
3 min 95.83 ± 5.89 108.33 ± 6.31 128.47 ± 12.52 107.08 ± 12.52 97.57 ± 10.40 94.03 ± 6.59
5 min 70.83 ± 5.89 141.67 ± 17.01 118.19 ± 12.90 107.64 ± 12.90 113.42 ± 7.59 114.76 ± 9.04
8 min 79.17 ± 5.89 131.67 ± 14.06 128.63 ± 3.00 125.25 ± 9.09 110.56 ± 9.37 108.47 ± 10.36
12 min 115.83 ± 4.12 96.71 ± 4.82 111.88 ± 3.37 109.17 ± 8.94 109.58 ± 10.83 95.69 ± 11.79
Total platelets (% total of 10 mL)
3 min 10.35 ± 1.38 18.81 ± 3.04 43.63 ± 6.13 51.47 ± 5.24 68.75 ± 6.13 75.91 ± 4.91
5 min 16.98 ± 1.92 42.49 ± 5.68 62.85 ± 5.61 82.76 ± 5.84 95.37 ± 1.61 94.98 ± 1.39
8 min 29.17 ± 5.89 73.32 ± 7.82 89.03 ± 3.61 96.06 ± 2.33 94.92 ± 3.26 89.21 ± 1.64
12 min 56.52 ± 0.92 84.88 ± 3.53 95.94 ± 1.71 94.09 ± 3.49 83.29 ± 6.89 81.69 ± 3.78
Concentration of platelets (% baseline)
3 min 103.54 ± 13.85 148.37 ± 18.84 228.55 ± 17.33 229.56 ± 7.03 237.83 ± 19.39 202.37 ± 14.43
5 min 87.40 ± 13.11 246.53 ± 15.47 230.32 ± 13.75 226.07 ± 17.03 202.67 ± 12.41 194.31 ± 17.79
8 min 118.06 ± 9.82 232.06 ± 17.75 215.84 ± 19.59 196.29 ± 18.40 166.54 ± 12.08 156.45 ± 10.10
12 min 176.82 ± 2.30 208.86 ± 17.64 195.88 ± 17.23 165.15 ± 12.57 146.76 ± 17.40 143.53 ± 12.30
Table 2 Properties of  the  blood cells, including  shape, 
density, surface area, radius, and  frequency distribution 
in whole blood
Platelets WBC RBC
Density (kg/m3) 1040–1065 1055–1085 1095–1100
Frequency (1/µL) 200,000 5000 5,000,000
Surface (µm2) 28 330 140
Radius (µm) 11.5 5–7.5 4
Volume (µm3) 14 200 92
Shape Irregular disk Spherical Biconcave
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In general, platelets were evenly distributed throughout 
a variety of protocols within the upper 3–6 plasma-rich 
layers (Figs. 3, 4, 5, 6, 7). Additionally, white blood cells 
required more pristine fine-tuning to reach adequate har-
mony within the upper plasma layers. Protocols within 
the 400–700g (5–8  min) range were able to accumulate 
platelets more evenly distributed throughout the upper 
layers, whereas slightly better optimization was required 
to effectively spread leukocytes within the upper plasma 
layers. Note that even though platelets were evenly dis-
tributed throughout the upper plasma layer, white blood 
cells typically did not fully distribute evenly throughout 
the upper 4–6 layers, with the greatest concentration 
remaining at the buffy coat layer (arrows, Fig. 4).
The most surprising finding from the present study 
was the marked difference in cell layer separation that 
occurred at the various protocols. Notably, inadequate 
testing of protocols may drastically lead to a poor yield 
of cells evenly distributed throughout the PRF clot. A 
400–700g protocol for 8 min was required to effectively 
separate the cell layers for solid-PRF protocols. Inter-
estingly, there was also variability reported between 
patients. As erythrocytes and other blood components 
also play a role in coagulation, as well as the hematocrit 
counts vary between patients and affect the size of PRF 
membranes [20], the present study also showed that not 
only the total plasma volume but also the cellular content 
of the layers were altered (Additional file 1: Figs. S1–S3). 
We have previously shown that both females and patients 
above the age of 65 typically have larger membranes as 
a result of their lower hematocrit counts [20]. Future 
research is needed to better understand how centrifuga-
tion speed and time may be further optimized to result 
in similar final cell concentrations from patients with 
Fig. 8 Illustrations comparing fixed‑angle and horizontal centrifuges. With horizontal centrifugation, a greater separation of blood layers based on 
density is achieved owing to the greater difference in RCF‑min and RCF‑max. Following centrifugation on fixed‑angle centrifuges, blood layers do 
not separate evenly, and as a result, an angled blood separation is observed. In contrast, horizontal centrifugation produces even separation. Owing 
to the large RCF values (~ 200–700g), the cells are pushed toward the outside and downwards. On a fixed‑angle centrifuge, cells are pushed toward 
the back of centrifugation tubes and then downwards/upwards based on cell density. These g‑forces produce additional shear stress on cells as 
they separate based on density along the back walls of centrifugation tubes. In contrast, horizontal centrifugation allows for the free movement 
of cells to separate into their appropriate layers based on density, allowing for better cell separation as well as less trauma/shear stress on cells. 
Modified from Miron et al. [16].
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different starting blood cell counts. In summary, patients 
with lower cell blood counts would theoretically require 
lower centrifugation speeds, and further computational 
research is likely needed to optimize the protocols.
Currently, one standard in the field of PRF is the novel 
use of injectable i-PRF [15]. Previously, our research 
group found that only slight increases in platelets and 
leukocytes were noted with failure to adequately accu-
mulate cells in the upper plasma layer owing to extremely 
low RCF values (60g) and centrifugation times (3–4 min) 
[16]. While our group reported a 33% increase in cell 
concentrations in i-PRF protocols, other groups have 
more recently reported similar findings [21]. In a study 
titled “Injectable platelet-rich fibrin: cell content, mor-
phological, and protein characterization”, only a slight 
increase in platelets (less than 33%) and leukocytes was 
observed following i-PRF protocols, with decreases in 
VEGF reported when compared to that in whole blood 
[21]. Altogether, these studies confirm that previously 
utilized i-PRF protocols (~ 60g for 3–4  min on a fixed-
angle centrifuge) are inadequately effective at separating 
blood cell layers owing to their considerable reduction in 
centrifugation speed and time. We found in the present 
study, that protocols at 100g or lower were inefficient at 
accumulate platelets and leukocytes in the upper plasma 
layer. It must therefore be highlighted that a limit exists 
with respect to the ‘low-speed centrifugation concept’, 
with further research being needed to further optimize 
fixed-angle centrifugation systems.
In the present study, the use of PRF produced via hori-
zontal centrifugation with the highest concentration 
of platelets and leukocytes was observed at higher and 
longer centrifugation speeds and times. By combining 
an increase in speed and time, up to a fourfold increase 
in platelet/leukocyte concentration and/or yield was 
observed when compared to the results of previously uti-
lized i-PRF protocols produced on a fixed-angle centri-
fuge [16]. The present study further questions the use of 
trademarks such as ‘leukocytes and platelet-rich fibrin’ or 
‘L-PRF’. As observed in our study, changes in centrifuga-
tion speeds and times can alter the final leukocyte con-
centrations/yields and may even further lead to actual 
reductions in leukocyte number when compared to that 
in whole blood (Table 1). Previously, we have shown how 
the production of L-PRF on a fixed angle-centrifuge actu-
ally led to an actual decrease in final leukocyte concentra-
tions when compared to those in whole blood [16]. In the 
present study, a protocol of 400–700g for 8 min produced 
via horizontal centrifugation led to increases in leukocyte 
concentrations. To the best of the authors knowledge, 
these procedures are the only protocols established with 
a reported increase in leukocyte concentrations found in 
solid-PRF-based protocols.
One of the principal advantages of utilizing the pre-
sent methodology to investigate cell layer separations 
was the ability to locate and quantify cell layer changes 
accurately over time and at different RCF values. The 
ability to quantify 960 CBCs favored a better under-
standing of the cell layer separation of PRF-based 
protocols. Future research aims to better understand 
how time versus speed affect blood cell layer changes 
and how patient variability can be fine-tuned to fur-
ther optimize the centrifugation protocols for PRF in 
patients with different hematocrit levels. This study 
further highlights the need for additional research in 
the field to further improve the understanding of cen-
trifugation protocols for the production of PRF.
Conclusion
The present study found that centrifugation speed and 
time greatly influenced the final cell counts in the upper 
PRF layers. In general, when compared to leukocytes, 
platelets more easily separated evenly into the plasma 
layers owing to their lower cellular density. Protocol time 
seemed to have a greater impact on the final cell layer 
separation when compared to speed. The optimal centrif-
ugation speed and time ranged between 400 and 700g for 
8 min for solid-PRF protocols (greater yield with evenly 
distributed cells) and 200–400g for 5 min for liquid-PRF 
(highest concentration of platelets/leukocytes). Notably, 
variability in patient baseline platelet/leukocyte counts 
significantly affected cell layer separation. This finding 
was more pronounced at lower centrifugation speeds.
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